EN
HI
Sun Pharmaceutical Industries Chart
Sun Pharmaceutical Industries Share Key Metrics
Volume
37.57 L
Market Cap
426841.69 CR
LTQ@LTP
10@1779.00
ATP
1780.02
Var Margin
12.5 %
Circuit Range
1610-1967.6
Delivery %
63.88 %
Value
668.68 CR
ASM/GSM
No
Market Lot
1
Summary
Sun Pharmaceutical Industries share price is ₹1779 as of 10 Jun, 2026. The stock Sun Pharmaceutical Industries intraday movement has stayed between ₹1766.10 and ₹1796.60, while on a 52-week basis,Sun Pharmaceutical Industries price 52 week high is ₹1916.60 & its 52 week low is ₹1548.00.
In terms of trading activity, Sun Pharmaceutical Industries has recorded a volume of 3756570 shares, The Sun Pharmaceutical Industries has a market cap of ₹2399334970 CR. The stock’s Average Traded Price (ATP) stands at ₹1780.02, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹1779.00.
Sun Pharmaceutical Industries operates within a circuit range of ₹1610.00 – ₹1967.60, with a Value of ₹668.68 CR. The Delivery Percentage for the day is 63.88%. Additionally, Sun Pharmaceutical Industries currently falls under the No framework, and trades with a market lot size of 1.
Sun Pharmaceutical Industries Fundamentals
P/E Ratio
37.38
P/B Ratio
5.14
Div. Yield
0.89
Sector P/E
67.41
Sector P/B
2.96
Sec. Div. Yield
0.54
Sun Pharmaceutical Industries Resistance and Support
Pivot 1788.6
Resistance
First Resistance
1803.7
Second Resistance
1818.6
Third Resistance
1833.7
Support
First Support
1773.7
Second Support
1758.6
Third Support
1743.7
Sun Pharmaceutical Industries Futures & Options
Sun Pharmaceutical Industries Option Chain
View Price, OI, Greeks & More...
30JUN26
1784.50
-9.40 (0.52%)
28JUL26
1794.00
-5.90 (0.33%)
25AUG26
1793.80
-23.60 (1.30%)
SUNPHARMA|30JUN26 CE 1760.00
43.30
-7.65 (-15.01%)
SUNPHARMA|30JUN26 PE 1780.00
24.6
0.2 (0.82%)
Sun Pharmaceutical Industries Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-22 | Audited Results & Final Dividend |
| 2026-01-31 | Quarterly Results & Interim Dividend |
| 2025-11-05 | Quarterly Results |
| 2025-07-31 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-01-31 | Quarterly Results & Interim Dividend |
Sun Pharmaceutical Industries News
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sun Pharmaceutical has scheduled three analyst and investor meetings in June 2026. These meetings include participation in the BofA India, Morgan Stanley India Investment Forum, and Citi India Conferences, all held in Mumbai. No unpublished price sensitive information will be disclosed.
May 27 2026 16:01:53
Sun Pharmaceutical Industries Ltd - 524715 - Additional Outcome Of The Board Meeting
Sun Pharma's Board of Directors approved the reclassification of certain promoter group individuals to the "Public" category. This reclassification is subject to approvals under SEBI Regulation 31A.
May 22 2026 18:17:30
Read More
Sun Pharmaceutical Industries Management
| Name | Position |
|---|---|
| Anoop Deshpande | Company Secretary & Compliance Officer |
| Dilip S Shanghvi | Chairman & Managing Director |
Sun Pharmaceutical Industries Similar Stocks
Divi's Laboratories Ltd.
6753.00
232.00 (3.56%)
Torrent Pharmaceuticals Ltd.
4472.90
62.50 (1.42%)
Apollo Hospitals Enterprise Ltd.
8524.00
165.50 (1.98%)
Cipla Ltd.
1376.50
-11.40 (0.82%)
Zydus Lifesciences Ltd.
1105.60
18.00 (1.66%)
Dr. Reddy's Laboratories Ltd.
1268.50
-7.10 (0.56%)
Lupin Ltd.
2264.20
9.70 (0.43%)
Mankind Pharma Ltd.
2391.00
33.60 (1.43%)
Sun Pharmaceutical Industries FAQs
The Buying Price of Sun Pharmaceutical Industries share is 1779 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Sun Pharmaceutical Industries stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sun Pharmaceutical Industries, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Sun Pharmaceutical Industries shares is 37.38. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Sun Pharmaceutical Industries shares is 5.14. Useful to assess the stock's value relative to its book value.
To assess Sun Pharmaceutical Industries’s valuation compare Sector P/E, P/B which are 67.41 & 2.96 with sector averages, along with growth rates and financial metrics.
The Market Cap of Sun Pharmaceutical Industries is 426841.69 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Sun Pharmaceutical Industries share price is 1916.60 & 1548.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Sun Pharmaceutical Industries belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
